Document Detail


Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma.
MedLine Citation:
PMID:  22940405     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Nonmalignant cutaneous findings associated with the use of vemurafenib have only recently been described in the literature. Patients receiving vemurafenib have exhibited cutaneous reactions including prominent follicular plugging, hand-foot skin reaction, exuberant seborrheic dermatitis-like hyperkeratosis of the face, keratosis pilaris, and diffuse spiny follicular hyperkeratosis. Many of these nonmalignant cutaneous findings are associated with abnormal follicular keratinization thought to be secondary to abnormal signaling of the mitogen-activated protein kinase pathway that occurs with the use of BRAF inhibitors. Whether underlying Ras mutations affect this abnormal signaling as in malignant lesions is still unknown. Different therapeutic options exist for these patients that may result in significant improvement in some of these nonmalignant cutaneous findings. Conservative treatment should focus on topical therapies such as topical retinoids or topical steroids. However, systemic therapies such as concomitant oral retinoids or MEK inhibitors should be considered for more severe or refractory cutaneous findings.
Authors:
Kevin P Boyd; Bethaney Vincent; Aleodor Andea; R Martin Conry; Lauren C Hughey
Related Documents :
9613265 - Requirements for target-controlled infusion of propofol to insert the laryngeal mask ai...
18041425 - Effectiveness of mouthpiece nebulization and nasal swab stick packing for topical anest...
11007085 - Photography of severe laryngeal obstruction.
9115605 - Early intragastric feeding of seriously burned and long-term ventilated patients: a rev...
23464875 - Frequency of malignant neoplasms in 257 chronic leg ulcers.
14616325 - Prevalence and predictive value of ionized hypocalcemia among critically ill patients.
Publication Detail:
Type:  Journal Article; Review     Date:  2012-08-30
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  67     ISSN:  1097-6787     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-19     Completed Date:  2013-01-22     Revised Date:  2014-04-08    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1375-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Drug Eruptions / etiology*,  therapy
Humans
Indoles / adverse effects*,  therapeutic use
Melanoma / drug therapy*,  secondary*
Skin Neoplasms / drug therapy*,  pathology*
Sulfonamides / adverse effects*,  therapeutic use
Chemical
Reg. No./Substance:
0/Indoles; 0/PLX4032; 0/Sulfonamides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dermatoscopy of hair shaft disorders.
Next Document:  Cutaneous gnathostomiasis: Report of 6 cases with emphasis on histopathological demonstration of the...